Clinical trials
Completed Inflammation trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,078 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 10 |
| 2001 | 11 |
| 2002 | 17 |
| 2003 | 27 |
| 2004 | 44 |
| 2005 | 47 |
| 2006 | 64 |
| 2007 | 68 |
| 2008 | 81 |
| 2009 | 95 |
| 2010 | 99 |
| 2011 | 112 |
| 2012 | 110 |
| 2013 | 108 |
| 2014 | 105 |
| 2015 | 104 |
| 2016 | 112 |
| 2017 | 105 |
| 2018 | 102 |
| 2019 | 101 |
| 2020 | 103 |
| 2021 | 102 |
| 2022 | 102 |
| 2023 | 83 |
| 2024 | 70 |
| 2025 | 43 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,078 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 21 |
| Appalachian State University | 19 |
| University of Florida | 19 |
| Radboud University Medical Center | 18 |
| University of Aarhus | 16 |
| Bausch & Lomb Incorporated | 15 |
| National Eye Institute (NEI) | 14 |
| Novo Nordisk A/S | 14 |
| University of California, Los Angeles | 14 |
| Massachusetts General Hospital | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammation | 2,078 |
| Obesity | 176 |
| Cardiovascular Diseases | 125 |
| Insulin Resistance | 116 |
| Diabetes Mellitus, Type 2 | 82 |
| Pain | 81 |
| Metabolic Syndrome | 77 |
| Atherosclerosis | 67 |
| Diabetes Mellitus | 53 |
| Asthma | 52 |
Trials
Showing 51 to 75 of 2,078. Each trial links to its page on Pharma Observatory.
1,978 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.